Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teun Bousema

Showing results (281-290 of 340) with videos related to

Pageof 34
Sort By:
Ebiomedicine|December 10, 2024
Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in NamibiaHenry Ntuku, Brooke Whittemore, Lucille Dausab, et al.
Malaria Journal|April 21, 2021
Maintaining Plasmodium falciparum gametocyte infectivity during blood collection and transport for mosquito feeding assays in the fieldHarouna M Soumare, Wamdaogo Moussa Guelbeogo, Marga van de Vegte-Bolmer, et al.
Plos Medicine|August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant dataLeen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trialAndré Lin Ouédraogo, Guido J H Bastiaens, Alfred B Tiono, et al.
The Lancet. Microbe|May 5, 2024
Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, MaliAlmahamoudou Mahamar, Merel J Smit, Koualy Sanogo, et al.
Genome Medicine|November 11, 2023
Rapid profiling of Plasmodium parasites from genome sequences to assist malaria controlJody E Phelan, Anna Turkiewicz, Emilia Manko, et al.
BMJ Open|March 13, 2024
Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trialMarta Moreno, Aissata Barry, Markus Gmeiner, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodiesEzra T Bekkering, Randy Yoo, Sophia Hailemariam, et al.
The Lancet. Microbe|May 11, 2022
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trialWill Stone, Almahamoudou Mahamar, Merel J Smit, et al.
Scientific Reports|May 31, 2022
SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patientsLisa Kurver, Corné H van den Kieboom, Kjerstin Lanke, et al.
Pageof 34

Showing results (281-290 of 340) with videos related to

Sort By:
Pageof 34
Ebiomedicine|December 10, 2024
Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in NamibiaHenry Ntuku, Brooke Whittemore, Lucille Dausab, et al.
Malaria Journal|April 21, 2021
Maintaining Plasmodium falciparum gametocyte infectivity during blood collection and transport for mosquito feeding assays in the fieldHarouna M Soumare, Wamdaogo Moussa Guelbeogo, Marga van de Vegte-Bolmer, et al.
Plos Medicine|August 14, 2025
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant dataLeen N Vanheer, Jordache Ramjith, Almahamoudou Mahamar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trialAndré Lin Ouédraogo, Guido J H Bastiaens, Alfred B Tiono, et al.
The Lancet. Microbe|May 5, 2024
Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, MaliAlmahamoudou Mahamar, Merel J Smit, Koualy Sanogo, et al.
Genome Medicine|November 11, 2023
Rapid profiling of Plasmodium parasites from genome sequences to assist malaria controlJody E Phelan, Anna Turkiewicz, Emilia Manko, et al.
BMJ Open|March 13, 2024
Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trialMarta Moreno, Aissata Barry, Markus Gmeiner, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodiesEzra T Bekkering, Randy Yoo, Sophia Hailemariam, et al.
The Lancet. Microbe|May 11, 2022
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trialWill Stone, Almahamoudou Mahamar, Merel J Smit, et al.
Scientific Reports|May 31, 2022
SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patientsLisa Kurver, Corné H van den Kieboom, Kjerstin Lanke, et al.
Pageof 34